All News

The rapid-acting insulin aspart biosimilar adds a third interchangeable option to NovoLog, with implications for pharmacy dispensing and counseling.

A target trial emulation found early remdesivir initiation was associated with reduced 1-year risk of graft loss and cardiovascular events.

Every pattern of hormonal contraceptive use was associated with subsequent semaglutide initiation, a signal pharmacists and prescribers should watch for.

Among adult patients experiencing a transfer to skilled nursing facilities, researchers provide a detailed look into medication restart patterns following deprescribing.

New survey data reveal information gaps in respiratory syncytial virus immunization decisions.

Based on discussions from a recent webinar debate on the 340B Drug Pricing Program, we’re revealing how differently key stakeholders see a program that pharmacists participate in every day.

Voluntary licensing agreements covering 129 low- and middle-income countries arrive as phase 3 trials continue.

In a technologically advanced health care landscape, solutions to address language barriers are necessary and can be the difference between life and death for complex medication regimens.

Large trial emulation study finds a 21% reduction in 3-year fracture risk compared with DPP-4 inhibitors, independent of weight loss or glycemic changes.

As COVID-19 shifts from emergency response to routine care, persistent inequities in vaccine access are quietly resurfacing.

Tom Kraus, JD, of ASHP, and Shawn Gremminger, MPP, of the National Alliance of Healthcare Purchaser Coalitions, face off on the 340B Drug Pricing Program.

Newly filed charters arrive as pharmacy groups already press HHS over similar changes to the CDC's vaccine advisory panel.

In part 2, Blank argues that the language on a medication’s label deserves the same regulatory scrutiny given to the drugs themselves and how they affect patients.

Viatris' new transdermal patch adds a low-dose estrogen option to the contraceptive landscape.

A study found antibody deficiencies and monoclonal immunoglobulins in a share of adults hospitalized with invasive pneumococcal disease.

Researchers explore prenatal alcohol use among expectant mothers in the US spanning 2011 to 2024.

A 4-year cohort study finds pneumococcal vaccine serotypes circulating and increasing among older adults with community-acquired pneumonia.

Study findings underscore health care’s gradual push into the technologically driven future of health care, leaving in-store destinations behind.

Managing diabetes has shifted from reactive monitoring to a proactive, technology-driven standard of care that emphasizes real-time data and personalized treatment.

Sharon Blank, CEO of RxTran and Language Scientific, discusses language hurdles in the safe delivery of medications for patients and pharmacists alike.

The opioid-free product pairs acetaminophen with naproxen in a single dose, giving pharmacists a new counseling point for patients.

The approval is backed by pivotal phase 3 trials and carries boxed warnings for suicidal ideation in pediatric patients and abuse potential.

Researchers design, implement, and evaluate the use of social determinants of health screening and referral services within Medicaid payer programs.

Positive results from TRIUMPH-2 and TRIUMPH-3 bring retatrutide's obesity program to 5 successful trials, with Lilly planning to submit in early 2027.

Pharmacists were asked about their perceived knowledge and attitudes toward patients with Down syndrome.

The autoinjector cuts administration to under 10 seconds, offering patients an at-home option for fluid overload in heart failure and chronic kidney disease.

A new survey shows widespread uncertainty about which vaccines the CDC recommends during pregnancy, underscoring the counseling role pharmacists play.

In the first of a 2-day hearing on peptide therapy access, the FDA votes in favor of approving 4 of the products discussed, with the potential for more on Friday.